Verve Therapeutics Inc
NASDAQ:VERV
Balance Sheet
Balance Sheet Decomposition
Verve Therapeutics Inc
Verve Therapeutics Inc
Balance Sheet
Verve Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
3
|
9
|
64
|
115
|
206
|
173
|
|
| Cash Equivalents |
3
|
9
|
64
|
115
|
206
|
173
|
|
| Short-Term Investments |
16
|
63
|
296
|
439
|
418
|
352
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
6
|
3
|
|
| Other Current Assets |
0
|
2
|
7
|
7
|
8
|
15
|
|
| Total Current Assets |
19
|
74
|
367
|
563
|
638
|
543
|
|
| PP&E Net |
2
|
4
|
9
|
111
|
108
|
97
|
|
| PP&E Gross |
2
|
4
|
9
|
111
|
108
|
97
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
5
|
10
|
17
|
|
| Other Long-Term Assets |
0
|
1
|
8
|
5
|
7
|
8
|
|
| Total Assets |
22
N/A
|
78
+263%
|
384
+390%
|
679
+77%
|
753
+11%
|
647
-14%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
0
|
7
|
2
|
7
|
5
|
|
| Accrued Liabilities |
1
|
7
|
15
|
33
|
30
|
35
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
4
|
|
| Total Current Liabilities |
4
|
7
|
22
|
35
|
37
|
43
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
12
|
10
|
5
|
93
|
116
|
111
|
|
| Total Liabilities |
16
N/A
|
17
+10%
|
27
+56%
|
128
+379%
|
153
+19%
|
154
+1%
|
|
| Equity | |||||||
| Common Stock |
26
|
125
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
21
|
67
|
187
|
344
|
544
|
743
|
|
| Additional Paid In Capital |
1
|
3
|
544
|
896
|
1 143
|
1 236
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
6
N/A
|
61
+939%
|
357
+483%
|
551
+54%
|
600
+9%
|
493
-18%
|
|
| Total Liabilities & Equity |
22
N/A
|
78
+263%
|
384
+390%
|
679
+77%
|
753
+11%
|
647
-14%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
46
|
46
|
49
|
62
|
82
|
89
|
|